Dailypharm Live Search Close

¡®Era of once-weekly growth hormones¡¦adherence is key¡¯

By Hwang, Byung-woo | translator Alice Kang

24.09.13 05:32:03

°¡³ª´Ù¶ó 0
Growth hormone deficiency drug Ngenla enters the market¡¦ convenience in administration is an advantage

Pain management remains a challenge compared to once-daily options... improvement in quality of life is key

"The frequency of drug administration is an important factor in the treatment of growth hormone deficiency. The emergence of a once-weekly dosing option is significant in terms of treatment adherence.¡¯

With the market for growth hormone injections rising rapidly, the diversified treatment options have been increasing market interest.

The introduction of once-weekly treatment options to the once-daily regimen has emphasized the importance of choosing the right treatment option for patients. 

Professor Masanobu Kawai (Osaka Women's and Children's Hospital( focused on the effect of the once-weekly growth hormone deficiency treatment.

 ¡ãProfessor Masanobu Kawai, Osaka Women


Growth hormon

Hwang, Byung-woo(tuai@dailypharm.com)
If you want to see the full article, please JOIN US (click)